MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Im, H.-J.
Right arrow Articles by Loh, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Im, H.-J.
Right arrow Articles by Loh, H. H.

Vol. 59, Issue 6, 1486-1496, June 2001

Transcriptional Modulation of Mouse µ-Opioid Receptor Distal Promoter Activity by Sox18

Hee-Jeong Im, Dmitri Smirnov, Tomoaki Yuhi, Shalini Raghavan, Jane E. Olsson, George E. Muscat, Peter Koopman, and Horace H. Loh

Department of Pharmacology, The University of Minnesota, Medical School, Minneapolis, Minnesota (H.-J.I., D.S., T.Y., S.R., H.H.L.); and Institute for Molecular Bioscience, The University of Queensland, Australia (J.E.O., G.E.M., P.K.)

Previously, we reported the presence of dual promoters, referred to as distal (DP) and proximal, with a negative regulatory element between them in the mouse µ-opioid receptor (mor) gene. Here we have identified a positive regulatory element influencing mor DP transcription, which contains multiple consensus binding motifs for Sox factors (sex-determining Sry-like high mobility group box-containing genes). In gel supershift assays, the Sox family member Sox18 bound directly to the multiple Sox consensus binding motifs of the mor DP enhancer. Overexpression of Sox18 cDNA increased luciferase activity regulated by the mor DP, and did so in a Sox18 concentration-dependent manner. In contrast, overexpression of another Sox member, Sox5, triggered no such trans-activation of mor DP-driven luciferase activity or DNA-protein binding activity. These results suggest that Sox18 directly and specifically stimulates mor gene expression, by trans-activating the mor DP enhancer.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
C. S. Kim, H. S. Choi, C. K. Hwang, K. Y. Song, B.-K. Lee, P.-Y. Law, L.-N. Wei, and H. H. Loh
Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene
Nucleic Acids Res., December 2, 2006; 34(22): 6392 - 6403.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. S. Choi, C. K. Hwang, C. S. Kim, K. Y. Song, P.-Y. Law, L.-N. Wei, and H. H. Loh
Transcriptional Regulation of Mouse {micro} Opioid Receptor Gene: Sp3 Isoforms (M1, M2) Function as Repressors in Neuronal Cells to Regulate the {micro} Opioid Receptor Gene
Mol. Pharmacol., May 1, 2005; 67(5): 1674 - 1683.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Dahan and L. J. Teppema
Influence of anaesthesia and analgesia on the control of breathing
Br. J. Anaesth., July 1, 2003; 91(1): 40 - 49.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. Im, M. R. Pittelkow, and R. Kumar
Divergent Regulation of the Growth-promoting Gene IEX-1 by the p53 Tumor Suppressor and Sp1
J. Biol. Chem., April 19, 2002; 277(17): 14612 - 14621.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics